Foghorn Therapeutics Inc.·4

Jan 24, 4:13 PM ET

Costa Carlos 4

4 · Foghorn Therapeutics Inc. · Filed Jan 24, 2025

Insider Transaction Report

Form 4
Period: 2025-01-22
Costa Carlos
Chief People Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-22$4.37/sh+115,000$502,550115,000 total
    Exercise: $4.37Exp: 2035-01-21Common Stock (115,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT